120 related articles for article (PubMed ID: 2720681)
41. [Radioimmunotherapy of solitary liver metastases using intratumor instillation of 131I-labeled monoclonal antibodies--initial results of a clinical study].
Müller-Gärtner HW; Montz R; Klapdor R; Hirschmann M; Rehpenning W; Langkowski J
Nuklearmedizin; 1988 Dec; 27(6):258-65. PubMed ID: 3217256
[TBL] [Abstract][Full Text] [Related]
42. Noradrenaline transporter gene transfer for radiation cell kill by 131I meta-iodobenzylguanidine.
Boyd M; Cunningham SH; Brown MM; Mairs RJ; Wheldon TE
Gene Ther; 1999 Jun; 6(6):1147-52. PubMed ID: 10455418
[TBL] [Abstract][Full Text] [Related]
43. Radiolabeled anti-CD33 monoclonal antibody M195 for myeloid leukemias.
Jurcic JG; Caron PC; Nikula TK; Papadopoulos EB; Finn RD; Gansow OA; Miller WH; Geerlings MW; Warrell RP; Larson SM
Cancer Res; 1995 Dec; 55(23 Suppl):5908s-5910s. PubMed ID: 7493368
[TBL] [Abstract][Full Text] [Related]
44. Relationship between surviving fractions using the colony methods, the LD50, and the growth delay after irradiation of human melanoma cells grown as multicellular spheroids.
Pourreau-Schneider N; Malaise EP
Radiat Res; 1981 Feb; 85(2):321-32. PubMed ID: 7465784
[No Abstract] [Full Text] [Related]
45. Single-Dose versus fractionated radioimmunotherapy of human colon carcinoma xenografts using 131I-labeled multivalent CC49 single-chain fvs.
Goel A; Augustine S; Baranowska-Kortylewicz J; Colcher D; Booth BJ; Pavlinkova G; Tempero M; Batra SK
Clin Cancer Res; 2001 Jan; 7(1):175-84. PubMed ID: 11205906
[TBL] [Abstract][Full Text] [Related]
46. Radiotoxicity of Auger electron-emitting estrogens in MCF-7 spheroids: a potential treatment for estrogen receptor-positive tumors.
Kearney T; Hughes A; Hanson RN; DeSombre ER
Radiat Res; 1999 May; 151(5):570-9. PubMed ID: 10319730
[TBL] [Abstract][Full Text] [Related]
47. Adjuvant 131I-anti-CEA-antibody radioimmunotherapy inhibits the development of experimental colonic carcinoma liver metastases.
Mahteme H; Lövqvist A; Graf W; Lundqvist H; Carlsson J; Sundin A
Anticancer Res; 1998; 18(2A):843-8. PubMed ID: 9615730
[TBL] [Abstract][Full Text] [Related]
48. 131I radioimmunotherapy and fractionated external beam radiotherapy: comparative effectiveness in a human tumor xenograft.
Barendswaard EC; O'Donoghue JA; Larson SM; Tschmelitsch J; Welt S; Finn RD; Humm JL
J Nucl Med; 1999 Oct; 40(10):1764-8. PubMed ID: 10520720
[TBL] [Abstract][Full Text] [Related]
49. Cell death induced by a 131I-labeled monoclonal antibody in ovarian cancer multicell spheroids.
Filippovich IV; Sorokina N; Robillard N; Faivre-Chauvet A; Bardies M; Chatal JF
Nucl Med Biol; 1996 Jul; 23(5):623-6. PubMed ID: 8905827
[TBL] [Abstract][Full Text] [Related]
50. Selective chromosomal damage and cytotoxicity of 125I-labeled monoclonal antibody 17-1a in human cancer cells.
Woo DV; Li D; Mattis JA; Steplewski Z
Cancer Res; 1989 Jun; 49(11):2952-8. PubMed ID: 2720655
[TBL] [Abstract][Full Text] [Related]
51. Comparisons of the efficacy of 186Re- and 131I-labeled antibody in multicell spheroids.
Langmuir VK; Mendonca HL; Vanderheyden JL; Su FM
Int J Radiat Oncol Biol Phys; 1992; 24(1):127-32. PubMed ID: 1512148
[TBL] [Abstract][Full Text] [Related]
52. Radiation response of multicellular spheroids initiated from five human melanoma xenograft lines. Relationship to the radioresponsiveness in vivo.
Rofstad EK; Wahl A; Brustad T
Br J Radiol; 1986 Oct; 59(706):1023-9. PubMed ID: 3768626
[TBL] [Abstract][Full Text] [Related]
53. A tumour spheroid model for antibody-targeted therapy of micrometastases.
Walker KA; Murray T; Hilditch TE; Wheldon TE; Gregor A; Hann IM
Br J Cancer; 1988 Jul; 58(1):13-6. PubMed ID: 3166889
[TBL] [Abstract][Full Text] [Related]
54. Cure, cell killing, growth delay and fragmentation of X-irradiated human melanoma HMV-I multicellular spheroids.
Kuwashima Y; Majima H; Okada S
Int J Radiat Biol; 1988 Jul; 54(1):91-104. PubMed ID: 2899617
[TBL] [Abstract][Full Text] [Related]
55. Comparisons of sectioned micro-TLD dose measurements with predicted dose from 131I-labeled antibody.
Langmuir VK; Wessels BW; Mendonca H; Yorke ED; Montilla L
Med Phys; 1992; 19(5):1213-6. PubMed ID: 1435601
[TBL] [Abstract][Full Text] [Related]
56. Radiation response of human melanoma multicellular spheroids measured as single cell survival, growth delay, and spheroid cure: comparisons with the parent tumor xenograft.
Rofstad EK; Wahl A; Brustad T
Int J Radiat Oncol Biol Phys; 1986 Jun; 12(6):975-82. PubMed ID: 3721939
[TBL] [Abstract][Full Text] [Related]
57. Differential cytotoxicity of [123I]IUdR, [125I]IUdR and [131I]IUdR to human glioma cells in monolayer or spheroid culture: effect of proliferative heterogeneity and radiation cross-fire.
Neshasteh-Riz A; Mairs RJ; Angerson WJ; Stanton PD; Reeves JR; Rampling R; Owens J; Wheldon TE
Br J Cancer; 1998; 77(3):385-90. PubMed ID: 9472632
[TBL] [Abstract][Full Text] [Related]
58. Radiosensitivity of human melanoma spheroids influenced by growth rate.
Schwachöfer JH; Crooijmans RP; Hoogenhout J; Jerusalem CR; Kal HB; Theeuwes AG
Int J Radiat Oncol Biol Phys; 1990 Nov; 19(5):1191-7. PubMed ID: 2254111
[TBL] [Abstract][Full Text] [Related]
59. Cure, regression and cell survival: a comparison of common radiobiological endpoints using an in vitro tumour model.
Durand RE
Br J Radiol; 1975 Jul; 48(571):556-71. PubMed ID: 1148588
[TBL] [Abstract][Full Text] [Related]
60. Sublethal damage repair in two radioresistant human tumor cell lines irradiated as multicellular spheroids.
Schwachöfer JH; Crooijmans RP; Hoogenhout J; Kal HB; Theeuwes AG
Tumour Biol; 1991; 12(4):207-16. PubMed ID: 1871510
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
